There’s good news for anyone who menstruates and doesn’t like the needles involved in blood testing. In January 2024, the biotechnology research company Qvin won FDA approval for their Q-Pad product – a menstrual pad with a removable strip to collect blood samples for clinical tests. It offers a needle-free way of testing menstrual blood for signs of diabetes.
This may only be the beginning of tapping into the huge potential of using menstrual blood in this way.